Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: A cohort study

The Lancet Diabetes and Endocrinology

Volumn 1, Issue 3, 2013, Pages 183-190

  Exalto, Lieza G ^a,b   Biessels, Geert Jan ^a   Karter, Andrew J ^b   Huang, Elbert S ^c   Katon, Wayne J ^d   Minkoff, Jerome R ^e   Whitmer, Rachel A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIABETES SPECIFIC DEMENTIA RISK SCORE; DIABETIC FOOT; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; COMPLICATION; DIABETES MELLITUS, TYPE 2; KAPLAN MEIER METHOD; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; DEMENTIA; DEPRESSION; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; EDUCATIONAL STATUS; HUMANS; KAPLAN-MEIER ESTIMATE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 84885952847     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70048-2     Document Type: Article

References (31)

1. Lutgers HL, Gerrits EG, Sluiter WJ, et al. Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10). PLoS One 2009, 4:e6817.
2. Strachan MW, Reynolds RM, Marioni RE, Price JF Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 2011, 7:108-114.
3. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
4. Carrillo MC, Brashear HR, Logovinsky V, et al. Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease. Alzheimers Dement 2013, 9:123-131.
5. Dehnel T The European dementia prevention initiative. Lancet Neurol 2013, 12:227-228.
6. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
7. Gage BF, van Walraven C, Pearce L, et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004, 110:2287-2292.
8. Barnes DE, Covinsky KE, Whitmer RA, et al. Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology 2009, 73:173-179.
9. Jessen F, Wiese B, Bickel H, et al. Prediction of dementia in primary care patients. PLoS One 2011, 6:e16852.
10. Reitz C, Tang MX, Schupf N, et al. A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol 2010, 67:835-841.
11. Kivipelto M, Ngandu T, Laatikainen T, et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006, 5:735-741.
12. Bruce DG, Davis WA, Casey GP, et al. Predictors of cognitive decline in older individuals with diabetes. Diabetes Care 2008, 31:2103-2107.
13. Hsu CC, Wahlqvist ML, Lee MS, Tsai HN Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 2011, 24:485-493.
14. Irie F, Fitzpatrick AL, Lopez OL, et al. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch Neurol 2008, 65:89-93.
15. Katon WJ, Lin EH, Williams LH, et al. Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study. J Gen Intern Med 2010, 25:423-429.
16. Lin CH, Sheu WH Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med 2013, 273:102-110.
17. Parikh NM, Morgan RO, Kunik ME, et al. Risk factors for dementia in patients over 65 with diabetes. Int J Geriatr Psychiatry 2011, 26:749-757.
18. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP, Selby JV Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301:1565-1572.
19. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001, 111:1-9.
20. Moffet HH, Adler N, Schillinger D, et al. Cohort Profile: The Diabetes Study of Northern California (DISTANCE)-objectives and design of a survey follow-up study of social health disparities in a managed care population. Int J Epidemiol 2009, 38:38-47.
21. Selby JV Linking automated databases for research in managed care settings. Ann Intern Med 1997, 127:719-724.
22. Krieger N Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992, 82:703-710.
23. Karter AJ, Newman B, Owell S, et al. Large-scale collection of family history data and recruitment of informative families for genetic analysis. J Registry Manag 1998, 25:7-12.
24. Huang ES, Karter AJ, Danielson KK, Warton EM, Ahmed AT The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study. J Gen Intern Med 2010, 25:141-146.
25. Chambless LE, Cummiskey CP, Cui G Several methods to assess improvement in risk prediction models: extension to survival analysis. Stat Med 2011, 30:22-38.
26. Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010, 33:264-269.
27. Cook NR Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008, 54:17-23.
28. Moons KG, Altman DG, Vergouwe Y, Royston P Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 2009, 338:b606.
29. Paul P, Pennell ML, Lemeshow S Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets. Stat Med 2013, 32:67-80.
30. Biessels GJ Intensive glucose lowering and cognition in type 2 diabetes. Lancet Neurol 2011, 10:949-950.
31. Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011, 10:969-977. for the ACCORD MIND investigators.